Genetic factors in IgA nephropathy

Annales de Medecine Interne

Volumn 150, Issue 2, 1999, Pages 86-90

  Schmidt, Susanne ^a   Ritz, Eberhard ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Glomerulonephritis; IgA

Indexed keywords

IMMUNOGLOBULIN A;

BLOOD PRESSURE REGULATION; DISEASE COURSE; DNA POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN PRODUCTION; KIDNEY BIOPSY; PATHOGENESIS; REVIEW;

EID: 0033030903     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. DE WERRA P, MOREL-MAROGER L, LEROUX-ROBERT C, RICHET G : Glomérulites a dépots d'IgA diffus dans le mesangium. Étude de 96 cas chez l'adulte. Schweiz Med Wochenschr 1973 ; 103 : 797-803.
2. JULIAN BA, QUIGGINS PA, THOMPSON JS, WOODFORD SY, GLEASON K, WYATT RJ : Familial IgA nephropathy: Evidence of an inherited mechanism of diease. N Engl J Med 1985; 312 : 202-8.
3. EGIDO J, JULIAN BA, WYATT RJ: Genetic factors in primary IgA nephropathy. Nephrol Dial Transplant 1987; 2: 134-142.
4. RAMBAUSEK M, HARTZ G, Waldherr R, ANDRASSY K, RITZ E: Familial glomerulonephritis. Pediatr Nephrol 1987; 1: 416-8.
5. LEVY M, LESAVRE P: Genetic factors in IgA nephropathy (Berger's disease). Adv Nephrol 1992; 21: 23-51.
6. SCOLARI F, AMOROSOS A, SAVOLDI S, PRATI E, SCAINI P, MANGANONI A et al.: Familial occurrence of primary glomerulonephritis: evidence for a role of genetic factors. Nephrol Dial Transplant 1992; 7: 587-96.
7. SCHENA FP: A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am J Med 1990; 89: 209-15.
8. ALLEN AC, HARPER SJ, FEEHALLY J: Galactosylation of N-linked and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol 1995, 100: 470-4
9. HIKI Y, IWASE H, SAITOH M, HORII Y, HOTTA K, KOBAYASHI Y: Reactivity of glomerular and serum IgA1 to jacalin in UgA nephropathy. Nephron 1996, 72: 429-35
10. GREER MR, BARRATT J, HARPER SJ, ALLEN AC, FEEHALLY J: The nucleotide sequence of the IgA1 hinge region in IgA nephropathy. Nephrol Dial Transplant 1998 (in press).
11. BERTHOUX FC, GAGNE A, SABATIER JC, DUCRET F, LE PETIT JC, MARCELLIN M et al.: HLA-Bw35 and mesangial IgA glomerulonephritis (letter). N Engl J Med 1978; 298: 1034.
12. FAUCHET R, LE POGAMP P, GENETET B, CHEVET D, GUÉGUEN M, SIMON P et al.: HLA-DR4 antigen and IgA nephropathy. Tissue Antigens 1980; 16: 405-10
13. KASAHARA M, HAMADA K, OKUYAMA T, ISHIKAWA N, OGASAWARA K, IKEDA H et al.: Role of HLA in IgA nephropathy. Clin Immunol Immunopathol 1982; 25: 189-95
14. NAITO S, KOHARA M, ARAKAWA K: Association of class II antigens of HLA with primary glomerulopathies. Nephron 1987; 45: 111-14.
15. MOORE RH, HITMAN GA, LUCAS EY, RICHARDS NT, VENNING MC, PAPIHA S et al.: HLA DQ region gene polymorphism associated with primary IgA nephropathy. Kidney Int 1990; 37: 991-95.
16. LI PK, BURNS AP, SO AK, PUSEY CD, FEHALLY J, REES AJ: The DQW7 allele at the HLA-DQB locus is associated with susceptibility to IgA-nephropathy in Caucasians. Kidney Int 1991; 39: 961-965.
17. RAMBAUSEK M, WALDHERR R, RITZ E: Immunogenetic findings in glomerulonephritis. Kidney Int 1993; 43 (Suppl 39): S3-8.
18. SCHMID M, MEYERS S, WEGNER R, RITZ E: Increased genetic risk of hypertension in glomerulonephritis. J Hypertens 1990; 8: 573-77.
19. AUTULY V, LARUELLE E, BENZIANE A, ANG KS, CAM G, RAMEE MP, SIMON P: Increased genetic risk of hypertension in immunglobulin A nephropathy but not in membranous nephropathy. J Hypertens 1991; 9 (suppl): S220-1.
20. RIGAT B, HUBERT C, ALHENC-GELAS, CAMBIEN F, CORVOL P, SOUBRIER F: An insertion/deletion-polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-6.
21. TIRET L, RIGAT B, VISKIVIS S, BREDA C, CORVOL P, CAMBIEN F et al.: Evidenve from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51: 197-205.
22. COSTEROUSSE O, ALLEGRINI J, LOPES M, ALHENC-GELAS F: Angiotensin I converting enzyme in human circulating mononuclear cells: Genetic polymorphism of expression in T-lymphocytes. Biochem J 1993; 290: 33-40.
23. COPPO R, AMORE A, GIANOGLIO B, CACACE G, PICIOTTO G, ROCCATELLO D et al.: Angiotensin local hyperactivity in the progression of IgA nephropathy. Am J Kidney Dis 1993, 27: 593-602.
24. MARRE M, BERNADET P, GALLOIS Y, SAVAGNER F, GUYENE T-T, HALLAB M, CAMBIEN F, PASSA P, ALHENC-GELAS F: Relationship between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinopathy and renal complications. Diabetes 1994; 43: 384-388.
25. HARDEN PN, GEDDES C, ROWE PA, MCILROY JH, BOULTON-JONES M, RODGER RSC et al.: Polymorphism in angiotensin-converting enzyme gene and progression of IgA nephropathy. Lancet 1995; 345: 1540-2.
26. YORIOKA T, SUEHIRO T, YASUOKA N, HASHIMOTO K, KAWADA M: Polymorphism of the angiotensin converting enzyme gene and clinical aspects of IgA nephropathy. Clin Nephrol 1995; 44: 80-5.
27. HUNLEY TE, JULIAN BA, PHILLIPS JA, SUMMAR ML, YOSHIDA H, HORN RG, BROWN NJ, FOGO A, ICHIKAWA I, KON V: Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 1996; 49: 571-7.
28. YOSHIDA H, MITARAI T, KAWAMURA T, KITAJIMA T, MIYAZAKI Y, NAGASAWA R et al.: Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 1995; 96: 2162-9.
29. HAMAGUCHI A, YOSHIDA H, MIYAZAKI Y, KAWAMURA T, MITARAI T, SAKAI O: The deletion polymorphism in the ACE gene is a risk factor for progression to renal failure independent of the M235T polymorphism in the angiotensinogen gene. J Am Soc Nephrol 1995; 6: 389a.
30. SCHMIDT S, STIER E, HARTUNG R, STEIN G, BAHNISCH J, WOODROFFE A et al.: No association of converting enzyme insertion/deletion polymorphism with immunoglobulin A glomerulonephritis. Am J Kidney Dis 1995; 5: 727-31.
31. PEI Y, SCHOLEY J, THAI K, SUZUKI M, CATTRAN D: Association of angiotensinogen gene T235 variant with progression of immunglobulin A nephropathy in Caucasian patients. J Clin Invest 1997; 100: 814-20.
32. TANAKA R, IIJIMA K, MURAKAMI R, KOIDE M, NAKAMURA H, YOSHIKAWA N: ACE gene polymorphism in childhood IgA nephropathy: Association with clinicopathologic findings. Am J Kidney Dis 1998; 31:774-9.
33. SCHMIDT A, KIENER HP, BARNAS U, ARIAS I, ILLIEVICH A, AUINGER M et al.: Graninger W, Kaider A, Mayer G: Angiotensin-converting enzyme polymorphism in patients with terminal renal failure. J Am Soc Nephrol 1996; 7: 314-7
34. HASHIMOTO K, IINO Y, OHSONO E, KAWABE M, HAYAMA N, TERASHI A: Association of angiotensin converting enzyme gene polymorphism with end-stage renal disease. J Am Soc Nephrol 1996; 7: 1319a.
35. CAMBIEN F, POIRIER O, LECERF L, EVANS A, CAMBOU JP, ARVEILER D et al.: Deletion polymorphism in the gene for angiotensin converting enzyme is a potential risk factor for myocardial infarction. Nature 1992; 359: 641-644.
36. RAYNOLDS MV, BRISTOW MR, BUSH EW, ABRAHAM WT, LOWES BD, ZISMAN LS et al.: Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 1993; 342: 1073-5.
37. OGURA M, YOSHIDA H, KAWAMURA T, HAMAGUCHI A, MIYAZAKI Y, MITARAI T et al.: The impact of the ACE gene polymorphism on slowly progressive IgA nephropathy my be linked to the glomerular size. J Am Soc Nephrol 1995, 6: 398a.
38. LOCATELLI F, CARBARNS IR, MASCHIO G, MANN JF, PONTICELLI C, RITZ E, et al.: Long-term progression of chronic renal insufficiency in the AIPRI Extension Study. The angiotensin-converting-enzyme inhibition in Progressive Renal Insufficiency Study Group. Kidney Int 1997; 63 (suppl): S63-6.
39. MORIYAMA T, KITAMURA H, OCHI S, IZUMI M, YOKOYAMA K, YAMAUCHI A et al.: Association of angiotensin converting enzyme gene polymorphism with susceptibility to antiproteinuric effect of angiotensin I converting enzyme inhibitors in patients with proteinuria. J Am Soc Nephrol 1995; 6: 1674-8.
40. KIYAMA S, NONOGUCHI H, TAJIMA A, SHIMADA H, TOMITA K: Impact of angiotensin converting enzyme (ACE) gene polymorphism on renoprotective effect of ACE inhibitor (ACE-I) in the patients with chronic renal failure. J Am Soc Nephrol 1996; 7: 616a.
41. SCHMIDT A, HAAS M, YLMAZ N, MAYER G: Angiotensin converting enzyme polymorphism determines the renal response to ACE inhibition in patients with proteinuric kidney disease. J Am Soc Nephrol 1996; 7: 1398a.
42. VAN DER KLEIJ FGH, SCHMIDT A, NAVIS GJ, HAS M, YILMAZ N, DE JONG PE, MAYER G, DE ZEEUW D: Angiotensin converting enzyme insertion/deletion polymorphism and short-term response to ACE inhibition: role of sodium status. Kidney Int 1997; 63 (Suppl): S23-6.
43. VAN ESSEN GG, RENSMA PL, DE ZEEUW D, SLUITER WJ, SCHEFFER H, APPERLOO AJ: Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy. Lancet 1996; 347: 95-6.
44. JEUNEMAITRE X, SOUBRIER F, KOTELEVTSEV YV, LIFTON RP, WILLIAMS CS, CHARRU A, HUNT SC, HOPKINS PN, WILLIAMS RR, LALOUEL J-M, CORVOL C: Molecular Basis of Human Hypertension: Role of Angiotensinogen. Cell 1992; 71: 169-80.
45. SCHMIDT S, SHARMA AM, ZILCH O, BEIGE J, WALLA-FRIEDEL M, GANTEN D, DISTLER A, RITZ E: Association of M235T variant of the angiotensinogen gene with familial hypertension of early onset. Nephrol Dial Transplant 1995; 10: 1145-8.
46. SCHMIDT S, BAHNISCH J, CAMPISE M, CLARKSON AR, FERRARIO F, PONTICELLI C et al.: The angiotensinogen gene M235T polymorphism and IgA nephropathy. J Am Soc Nephrol 1996; 7: 1863a.
47. YOSHIDA H, HAMAGUCHI A, SHIMODA M, ETO T, KAWAMURA T, HUNLEY T, KON V, MITARAI T, SAKAI O: Does the A1166C polymorphism in the angiotensin type 1 receptor gene have an influence on the progression to renal failure? J Am Soc Nephrol 1995; 6: 409a.